Risk Matters: Tariff Risks and Opportunities for Pharma Manufacturers
By Clifford Rossi The latest salvo in the emerging global tariff tiff has set its sights on the pharma sector. Aiming to stabilize US drug supplies, tariffs may have the opposite effect while posing a number of key risks to pharma companies large and small …